Cyclo(L-Phe-L-Pro)

Cyclo(L-Phe-L-Pro)
Product Name Cyclo(L-Phe-L-Pro)
CAS No.: 3705-26-8
Catalog No.: CFN96129
Molecular Formula: C14H16N2O2
Molecular Weight: 244.3 g/mol
Purity: >=98%
Type of Compound: Alkaloids
Physical Desc.: Oil
Targets: Antifection
Source: From Phellinus igniarius
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price: $238/10mg
Cyclo(L-Phe-L-Pro) shows antifungal and broad spectrum antibacterial activities, it exhibits activity against methicillin-resistant S. aureus ATCC 43300 and Enterococcus raffinosus, with low toxicity against human hepatoma HepaRG cells.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Phytomedicine.2022, 100:154058.
  • J Inflamm Res.2022, 15:5347-5359.
  • Int J Mol Sci.2019, 21(1):E265
  • European Journal of Integrative Medicine2018, 20:165-172
  • J Nat Med.2022, 76(1):59-67.
  • Chemistry of Plant Materials.2019, 215-222
  • J Ethnopharmacol.2017, 197:157-164
  • Int. J. Mol. Sci.2022, 23(14),7699;
  • J Chromatogr A.2022, 1685:463640.
  • Phytomedicine2022, 104:154318
  • Fumitremorgin B

    Catalog No: CFN89011
    CAS No: 12626-17-4
    Price: Inquiry(manager@chemfaces.com)
    Heterophyllin B

    Catalog No: CFN90627
    CAS No: 145459-19-4
    Price: $268/20mg
    Rubiyunnanin C

    Catalog No: CFN91927
    CAS No: 1261030-04-9
    Price: Inquiry(manager@chemfaces.com)
    Astin A

    Catalog No: CFN95187
    CAS No: 151201-75-1
    Price: $318/10mg
    Astin B

    Catalog No: CFN95188
    CAS No: 151201-76-2
    Price: $318/10mg
    Astin C

    Catalog No: CFN95189
    CAS No: 148057-23-2
    Price: $318/10mg
    Segetalin A

    Catalog No: CFN93198
    CAS No: 161875-97-4
    Price: $368/5mg
    Beauvericin

    Catalog No: CFN91404
    CAS No: 26048-05-5
    Price: Inquiry(manager@chemfaces.com)
    zeta-Clausenamide

    Catalog No: CFN95745
    CAS No: 136173-85-8
    Price: $318/5mg
    Cyclo(D-Phe-L-Pro)

    Catalog No: CFN96110
    CAS No: 26488-24-4
    Price: $238/10mg
    Appl Environ Microbiol. 2002 Sep;68(9):4322-7.
    Lactobacillus plantarum MiLAB 393 produces the antifungal cyclic dipeptides cyclo(L-Phe-L-Pro) and cyclo(L-Phe-trans-4-OH-L-Pro) and 3-phenyllactic acid.[Pubmed: 12200282]
    We have isolated a Lactobacillus plantarum strain (MiLAB 393) from grass silage that produces broad-spectrum antifungal compounds, active against food- and feed-borne filamentous fungi and yeasts in a dual-culture agar plate assay.
    METHODS AND RESULTS:
    Fusarium sporotrichioides and Aspergillus fumigatus were the most sensitive among the molds, and Kluyveromyces marxianus was the most sensitive yeast species. No inhibitory activity could be detected against the mold Penicillium roqueforti or the yeast Zygosaccharomyces bailii. An isolation procedure, employing a microtiter well spore germination bioassay, was devised to isolate active compounds from culture filtrate. Cell-free supernatant was fractionated on a C(18) SPE column, and the 95% aqueous acetonitrile fraction was further separated on a preparative HPLC C(18) column. Fractions active in the bioassay were then fractionated on a porous graphitic carbon column. The structures of the antifungal compounds Cyclo(L-Phe-L-Pro), cyclo(L-Phe-trans-4-OH-L-Pro) and 3-phenyllactic acid (L/D isomer ratio, 9:1), were determined by nuclear magnetic resonance spectroscopy, mass spectrometry, and gas chromatography. MIC values against A. fumigatus and P. roqueforti were 20 mg ml(-1) for Cyclo(L-Phe-L-Pro) and 7.5 mg ml(-1) for phenyllactic acid.
    CONCLUSIONS:
    Combinations of the antifungal compounds revealed weak synergistic effects. The production of the antifungal cyclic dipeptides Cyclo(L-Phe-L-Pro) and cyclo(L-Phe-trans-4-OH-L-Pro) by lactic acid bacteria is reported here for the first time.
    J Microbiol Biotechnol. 2017 Jul 28;27(7):1249-1256.
    Isolation, Purification, and Characterization of Five Active Diketopiperazine Derivatives from Endophytic Streptomyces SUK 25 with Antimicrobial and Cytotoxic Activities.[Pubmed: 28535606]
    In our search for new sources of bioactive secondary metabolites from Streptomyces sp., the ethyl acetate extracts from endophytic Streptomyces SUK 25 afforded five active diketopiperazine (DKP) compounds.
    METHODS AND RESULTS:
    The aim of this study was to characterize the bioactive compounds isolated from endophytic Streptomyces SUK 25 and evaluate their bioactivity against multiple drug resistance (MDR) bacteria such as Enterococcus raffinosus, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumanii, Pseudomonas aeruginosa, and Enterobacter spp., and their cytotoxic activities against the human hepatoma (HepaRG) cell line. The production of secondary metabolites by this strain was optimized through Thornton's medium. Isolation, purification, and identification of the bioactive compounds were carried out using high-performance liquid chromatography, high-resolution mass liquid chromatography-mass spectrometry, Fourier transform infrared spectroscopy, and nuclear magnetic resonance, and cryopreserved HepaRG cells were selected to test the cytotoxicity. The results showed that endophytic Streptomyces SUK 25 produces four active DKP compounds and an acetamide derivative, which were elucidated as cyclo-(L-Val-L-Pro), cyclo-(L-Leu-L-Pro), Cyclo(L-Phe-L-Pro), cyclo-(L-Val-L-Phe), and N-(7-hydroxy-6-methyl-octyl)-acetamide. These active compounds exhibited activity against methicillin-resistant S. aureus ATCC 43300 and Enterococcus raffinosus, with low toxicity against human hepatoma HepaRG cells.
    CONCLUSIONS:
    Endophytic Streptomyces SUK 25 has the ability to produce DKP derivatives biologically active against some MDR bacteria with relatively low toxicity against HepaRG cells line.
    Rhamnocitrin 3-apiosyl-(1->2)-glucoside

    Catalog No: CFN95145
    CAS No: 148031-68-9
    Price: $318/10mg
    3-Hydroxy-4',5-dimethoxystilbene

    Catalog No: CFN95199
    CAS No: 58436-29-6
    Price: $318/10mg
    Biatractylolide

    Catalog No: CFN95205
    CAS No: 182426-37-5
    Price: $268/10mg
    Isoeuphorbetin

    Catalog No: CFN95207
    CAS No: 50677-55-9
    Price: $318/5mg
    Ginsenoside Rd2 (Quinquenoside L10)

    Catalog No: CFN95231
    CAS No: 83480-64-2
    Price: $318/10mg
    Vaccarin E

    Catalog No: CFN95252
    CAS No: 2252345-81-4
    Price: $318/10mg
    Dioscoreside C

    Catalog No: CFN95345
    CAS No: 344912-80-7
    Price: $318/5mg
    trans-Psoralenoside

    Catalog No: CFN95349
    CAS No: N/A
    Price: $318/5mg
    Fragransin B1

    Catalog No: CFN95443
    CAS No: 112516-03-7
    Price: $318/5mg
    8-Epiloganin

    Catalog No: CFN95478
    CAS No: 79172-04-6
    Price: $318/20mg